Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial
Elizabeth R. Plimack, Catherine M. Tangen, Melissa Plets, Rutika Kokate, Joanne Xiu, Chadi Nabhan, Eric A. Ross, Erin Grundy, Woonyoung Choi, Colin P N Dinney, I-Ling C Lee, Megan Fong, M. Scott Lucia, Siamak Daneshmand, Dan Theodorescu, Amir Goldkorn, Seth P. Lerner, Thomas W. Flaig, David J. McConkey
Topics & Concepts
MedicineBladder cancerCystectomyGemcitabineOncologyChemotherapyNeoadjuvant therapyInternal medicineCisplatinCancerBreast cancerBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrological Disorders and Treatments